RPSG Ventures Limited has turned profitable for the quarter ended September 30, 2026, reporting a consolidated net profit of Rs 114.54 crore compared to a loss of Rs 41.13 crore in the previous year. Revenue from operations grew 21.5% to Rs 3,243.49 crore. The company also announced a major restructuring plan involving the acquisition of Clarionix Healthcare and the proposed amalgamation of Woodlands Multispeciality Hospital.
RPSG Ventures Posts Profit Turnaround in Q2 FY27
Net Profit: Rs 114.54 crore vs. Loss of Rs 41.13 crore in Q2 FY26
Revenue from Operations: Rs 3,243.49 crore, up 21.5% year-on-year
Reader Takeaway: Strong revenue growth driven by business process outsourcing and a strategic pivot into healthcare through new hospital amalgamations.
What just happened
RPSG Ventures has released its consolidated financial results for the quarter ended September 30, 2026. The company successfully transitioned from a loss-making position in the year-ago quarter to a net profit of Rs 114.54 crore. This growth was underpinned by a 21.5% increase in total revenue, which reached Rs 3,243.49 crore. The business process outsourcing segment remained the primary engine of this growth, contributing Rs 2,905.76 crore to the total topline.
Why this matters
The financial turnaround signals operational efficiency improvements across the group's diverse portfolio. Beyond the earnings, the company is signaling a major shift in business strategy. The board has approved the acquisition of 100% equity in Clarionix Healthcare Private Limited and initiated a formal scheme to amalgamate Woodlands Multispeciality Hospital Limited with the company. This restructuring is aimed at consolidating and expanding the group's footprint within the healthcare sector.
Corporate Developments
The amalgamation process for Woodlands Multispeciality Hospital includes a strategic transfer of the Hospital and Nursing Undertaking to the wholly-owned subsidiary, Clarionix, on a slump sale basis. This move, set for an appointed date of April 1, 2027, is subject to necessary regulatory and shareholder approvals. These steps reflect a proactive approach to aligning the group's assets with evolving market opportunities in healthcare.
Context metrics
For the half-year ended September 30, 2026, the company posted a cumulative revenue of Rs 6,819.93 crore and a net profit of Rs 367.63 crore. Standalone results for the quarter were stable, with a profit of Rs 1.76 crore on revenue of Rs 75.12 crore.
What to track next
Investors should monitor the regulatory progress of the Woodlands Multispeciality Hospital amalgamation. Additionally, the performance of the newly acquired Clarionix Healthcare entity will be a key indicator of how effectively the company executes its new healthcare-focused strategy in the upcoming quarters.